Douglas

Goldman Sachs downgraded Douglas from “hold” to “sell” and cut the price target from €9 to €7, sending the stock down to about €8.06. The move followed weaker Q3 figures: revenue down 2.0% to €987.8m and adjusted EBITDA down 19.4%, while management left the full-year guidance unchanged. Analysts are split (4 buy / 4 hold / 1 sell); price targets range from €7.00 to €14.20. The InvestingPro fair value is €10.16, indicating upside versus the current share price. » More on de.investing.com

Goldman Sachs lowers its rating for Douglas from "neutral" to "sell" and cuts the 12-month price target to €7, citing structural pressure in the European cosmetics market and intensified competition. Douglas reported Q3 revenue falling to €988m (−2%) and adjusted EBITDA of €127.5m (−19%), with margins and like-for-like sales declining. Goldman Sachs trimmed EBIT forecasts for 2027/2028, expects no net new openings and anticipates further like-for-like sales declines. Douglas confirms its full-year guidance for 2025/26 with stable revenue growth of 0–1% and plans a review of its store network and a strategy update in Q4. » More on de.investing.com

Douglas reported a 2.0% decline in sales in the third quarter to around €988 million and an adjusted EBITDA that fell by almost one-fifth to €127.5 million; the adjusted operating margin stood at 12.9%. Net result was a loss of €2.6 million after a profit of €17.3 million a year earlier. The company confirmed the full-year targets lowered in June (revenue growth 0–1%; revenues €4.58–4.63 billion; adjusted EBITDA margin around 15%) and announced measures for price adjustments, acceleration of the omnichannel transformation, a review of the store network, and higher technology investments; details will follow in the fourth calendar quarter. » More on finanzen.net